Cyclobenzaprine Hcl
Product Images NDC 61919-901

3 FDA label images from Direct_rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hcl (NDC 61919-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

414-60 (414 60)

414-60 (414 60)
Cyclobenzaprine HCL 7.5 mg, bottle label for 60 tablets, packaged and distributed by Direct_Rx. The label includes the NDC number 61919-414-60, lot number, expiration date 11/19, and a warning about drowsiness, alcohol use, and operating machinery. Each tablet contains 7.5 mg of cyclobenzaprine hydrochloride, USP.*
FDA Label Image

681-90 (681 90)

681-90 (681 90)
Packaging label for Cyclobenzaprine HCl 7.5mg tablets, containing 90 tablets. The label identifies it as a generic for Flexeril and states each tablet contains 7.5mg cyclobenzaprine hydrochloride USP. Distributed by Direct Rx, with lot and expiration date details also visible. Warning about drowsiness, alcohol use, and machinery operation is included.*
FDA Label Image

901-30 (901 30)

901-30 (901 30)
Label for Cyclobenzaprine HCl 5mg tablets, packaged as 30 count. The label states it is a generic for Flexeril and contains Cyclobenzaprine HCl USP 5 mg per tablet. It includes lot number 26SE1703 with a discard after date of 02/19. Labeler is Direct Rx, Alpharetta, GA. The label also contains cautionary statements regarding prescription use and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.